Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn V Papp

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
JAMA Neurology|April 12, 2016
Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention TrialsElizabeth C Mormino, Kathryn V Papp
Journal of Alzheimer'S Disease : JAD|May 22, 2018
Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's DiseaseElizabeth C Mormino, Kathryn V Papp
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 1, 2021
Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trialsDorene M Rentz, Kathryn V Papp
Brain and Cognition|April 19, 2012
Editorial to accompany--training the brain: fact and fad in cognitive and behavioral remediationKathryn V Papp, Peter J Snyder
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 3, 2009
Immediate and delayed effects of cognitive interventions in healthy elderly: a review of current literature and future directionsKathryn V Papp, Stephen J Walsh, Peter J Snyder
Brain and Cognition|September 6, 2011
Biological markers of cognition in prodromal Huntington's disease: a reviewKathryn V Papp, Richard F Kaplan, Peter J Snyder
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 23, 2021
Current advances in digital cognitive assessment for preclinical Alzheimer's diseaseFredrik Öhman, Jason Hassenstab, David Berron, et al.
Plos One|July 23, 2011
Detecting subtle changes in visuospatial executive function and learning in the amnestic variant of mild cognitive impairmentKathryn V Papp, Peter J Snyder, Paul Maruff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2009
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsorsPeter J Snyder, Kathryn V Papp, Jennifer Bartkowiak, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 22, 2017
Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5Kathryn V Papp, Dorene M Rentz, Irina Orlovsky, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
JAMA Neurology|April 12, 2016
Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention TrialsElizabeth C Mormino, Kathryn V Papp
Journal of Alzheimer'S Disease : JAD|May 22, 2018
Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's DiseaseElizabeth C Mormino, Kathryn V Papp
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 1, 2021
Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trialsDorene M Rentz, Kathryn V Papp
Brain and Cognition|April 19, 2012
Editorial to accompany--training the brain: fact and fad in cognitive and behavioral remediationKathryn V Papp, Peter J Snyder
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 3, 2009
Immediate and delayed effects of cognitive interventions in healthy elderly: a review of current literature and future directionsKathryn V Papp, Stephen J Walsh, Peter J Snyder
Brain and Cognition|September 6, 2011
Biological markers of cognition in prodromal Huntington's disease: a reviewKathryn V Papp, Richard F Kaplan, Peter J Snyder
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 23, 2021
Current advances in digital cognitive assessment for preclinical Alzheimer's diseaseFredrik Öhman, Jason Hassenstab, David Berron, et al.
Plos One|July 23, 2011
Detecting subtle changes in visuospatial executive function and learning in the amnestic variant of mild cognitive impairmentKathryn V Papp, Peter J Snyder, Paul Maruff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2009
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsorsPeter J Snyder, Kathryn V Papp, Jennifer Bartkowiak, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 22, 2017
Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5Kathryn V Papp, Dorene M Rentz, Irina Orlovsky, et al.
Pageof 13